NCT06368947

Brief Summary

The research is a randomized controlled experimental study. The population of the research will consist of 10-18 year old children who were diagnosed with acute lymphoblastic leukemia and received chemotherapy, who were admitted to the Children's Hematology Clinic of Adana City Training and Research Hospital between 19.05.2024 and 19.05.2025. Therapeutic play sessions will occur over a 4-week period during chemotherapy treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
4mo left

Started Apr 2024

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Apr 2024Sep 2026

First Submitted

Initial submission to the registry

April 12, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 16, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

April 29, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2024

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 29, 2026

Expected
Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

8 months

First QC Date

April 12, 2024

Last Update Submit

January 20, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain Tolerance Scale for Children with Cancer

    The scale was created to develop a tool to measure psychological acceptance in children experiencing pain during cancer treatment. The test version of the scale was conducted on children between the ages of 7 and 18 who were receiving cancer treatment. The Turkish reliability and validity study of the scale was conducted and it was found suitable for use in Turkish children with cancer. The scale is a 7-point Likert type scale consisting of 20 items (0 = strongly disagree and 6 = strongly agree). Some items in the scale (1, 2, 3, 5, 6, 7, 8, 9, 11, 13, 14, 15, 16, 18, 20 items) are reverse coded. The minimum score to be obtained from the scale is 0 and the maximum score is 120. Increasing scale scores indicate an increase in the level of acceptance.

    12 months

  • Emotion Regulation Scale for Children and Adolescents

    The scale was adapted to Turkish in 2021. The scale is a self-rating scale created to evaluate the differences in the use of two emotion regulation strategies. The scale consists of two subscales, reappraisal and suppression, and 10 items. Evaluation is made with a 5-point Likert type rating. Items 1, 3, 5, 7, 8, and 10 of the reevaluation subscale; Items 2, 4, 6, and 9 represent the suppression subscale. High scores obtained from the subscales indicate that the emotion regulation strategy represented by the subscale is frequently used.

    12 months

Study Arms (2)

intervention

EXPERIMENTAL

Therapeutic play sessions will be organized twice a week for 4 weeks during chemotherapy treatment for children diagnosed with acute lymphoblastic leukemia in the intervention group.

Behavioral: Therapeutic Play

control

NO INTERVENTION

Routine treatment will be applied to children in the control group receiving chemotherapy during their treatment.

Interventions

Therapeutic play sessions will be organized twice a week for 4 weeks during chemotherapy treatment for children diagnosed with acute lymphoblastic leukemia in the intervention group.

intervention

Eligibility Criteria

Age10 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Between the ages of 10-18
  • Diagnosed with acute lymphoblastic leukemia
  • Those receiving chemotherapy treatment
  • Children who do not have a chronic disease other than the diagnosis of the disease in question

You may not qualify if:

  • Under 10 years of age or over 18 years of age
  • Diagnosed other than acute lymphoblastic leukemia
  • Not receiving chemotherapy treatment
  • Children with chronic diseases other than the diagnosis of the disease in question

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ataturk University Nursing of Faculty

Erzurum, Erzurum, 25240, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Neoplasms

Interventions

Play Therapy

Intervention Hierarchy (Ancestors)

Sensory Art TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 12, 2024

First Posted

April 16, 2024

Study Start

April 29, 2024

Primary Completion

December 29, 2024

Study Completion (Estimated)

September 29, 2026

Last Updated

January 22, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

THE ARTICLE IS INTENDED TO BE SHARED AFTER IT IS PUBLISHED

Locations